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Malaria is one of the most widely spread human diseases today and constitutes 
a  major public health  problem for a  large part of the world's population.  The 
dramatic rise of the disease since the mid-1960's has resulted in renewed attempts 
to find ways of controlling the disease by immunological measures. Although the 
immune response to the malaria parasites is strictly regulated by the T  cell system 
and  may at  least  in  part  be cell  mediated  (1-3),  there  is  good  evidence  that 
antibodies  play  an  important  role  in  providing  protection  (4,  5).  Therefore, 
major efforts are now being made to characterize plasmodial antigens that may 
elicit protective humoral immune responses and thus may be suitable candidates 
for  malaria  vaccines  (6).  In  the  past  few years,  conspicuous  advances  in  this 
direction have been made with regard to the plasmodial sporozoites, i.e., the life 
cycle forms of the parasite which the mosquito transmits to the mammalian  host 
(7, 8).  However, since mortality and morbidity of the disease are caused by the 
asexual blood stages of the parasite,  it is generally agreed that development of 
vaccines against  these forms is of equally high  priority in  malaria  research  (9). 
Here,  some  of the  antigens  of special  interest  are  those  which  give  rise  to 
antibodies interfering with reinvasion of noninfected erythrocytes (E)  a and with 
intraerythrocytic growth (10-14) or with the sequestration of infected E, thereby 
preventing their destruction in the spleen (15,  16).  Such antigens appear to be 
derived from the mature blood forms (schizonts, merozoites) of the parasite and/ 
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or may also be located on the surface of infected E.  However, because of the 
complexity of the immune  response of the Plasmodium-infected  host,  the char- 
acterization of these antigens poses some major logistic problems, including the 
existence of an antigenic variability both between and within strains of a  given 
plasmodial species (17-19). 
By means of immunofluorescence (IF) and an enzyme-linked immunosorbent 
assay (ELISA) we have identified a  new antigenic modification of the surface of 
human  E  infected with Plasmodium falciparum,  the  most  lethal  of the  human 
malaria parasites.  These antigens are recognized by antibodies from patients or 
immune individuals and are present on the surface of E containing early stages 
of the  parasite  already  shortly after  invasion.  By  eluting  antibodies  from  the 
surface of infected E, we have been able to show that the major antigen involved 
in this reaction is a  parasite-derived polypeptide of 155,000  mol wt,  probably 
deposited on the E by the invading merozoite.  ~ 
Materials and Methods 
Parasites 
The main source of parasites was a  Tanzanian strain of Plasmodiumfalciparum (F32) 
isolated in 1978 (21) and cultured in vitro in blood group O + E according to Trager and 
Jensen (22). Parasites were also obtained from the blood of patients with acute P.falciparum 
infection. 
Immune Sera 
Immune sera were from Swedish or South American (Colombian) patients with acute 
P. falciparum malaria or from Africans living in a holoendemic area of Liberia with high 
transmission ofP. falciparum.  For details see (23). 
E Monolayers 
Infected E (El) from P. falciparum cultures (parasitemia, 5-10%) or freshly drawn from 
infected patients (parasitemia, usually 3-5%) were sedimented by centrifugation, washed 
three to four times with Tris-buffered Hanks' solution (TBH) (10 ml 0.15 M Tris buffer, 
pH 7.2, 90 ml 0.9% NaC1, 100 ml Hanks' solution). They were then diluted to give 1% 
suspensions. E from noninfected cultures (E0) were used for control. Eight-well multitest 
slides (Flow Laboratories, Rockville, MD) were treated for 30 rain with one drop per well 
(~20 #1) of a coating buffer, pH 9.6 (1.59 g Na2COs,  2.93 g NaHCOs, 200 mg NaNs/ 
liter). Immediately after aspiration of the coating buffer, one drop of the 1% E suspensions 
was added to each well and the cells were left to settle for 30 rain at room temperature. 
Unbound E were rinsed off by gentle shaking of the slides,  immersed upside down in a 
petri dish filled with TBH. The wet E monolayers were quickly but gently covered (on 
top) with  1-2 mi of 1% glutaraldehyde (GA) in phosphate-buffered saline (PBS). After 
-10 s, the GA solution was decanted and fixation was repeated once. The slides  were 
then washed with distilled water and air-dried. They could be stored at -20°C for many 
months with fully retained reactivity. 
IF of GA-fixed and Air-dried Monolayers 
The slides were treated sequentially for 30 min with 20 ~1 of (a) various dilutions of 
immune or normal human serum; (b) affinity-purified and biotinylated goat antibodies to 
human IgG (reacting with both heavy and light chains, 30 t~g]ml; Vector Laboratories, 
Inc., Burlingame, CA); and (c) avidin conjugated with fluorescein isothiocyanate (50/~g/ 
These results have been presented in a preliminary form at recent meetings: see Scand.  J. Immunol. 
(1983) 18:71 (Abstr.) and Proc. 5th Int. Congr. Immunol., Kyoto, Japan, August 21-27, 1983, p. 
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ml; Vector Laboratories, Inc.). Between the incubations, the slides were washed with TBH 
supplemented with 50 #1 Tween 20 per  100 mi. All incubations were performed at room 
temperature  in  a  humid  chamber.  To  visualize  parasitized  E,  the  monolayers  were 
counterstained after the IF staining by adding one drop per well of ethidium bromide (10 
#g/ml; Sigma Chemical Co., St. Louis, MO). After a few seconds, the slides were washed 
with  distilled  water,  mounted,  and  scored  with  a  100x  oil  immersion  lens in  incident 
ultraviolet  light  in  a  Zeiss  Universal  research  microscope (Carl  Zeiss  Co.,  Stockholm, 
Sweden) equipped for simultaneous observation of IF (green) and nuclear staining (oran  .ge) 
(band  filter  450-490,  beam  splitter  FT  510,  and  barrier  filter  LP520).  Extra  barrier 
filters LP560 or LP590 were used for exclusive observation of IF or ethidium bromide 
fluorescence, respectively. 
Inhibition of IF 
Lysates of Ei or Eo.  Monolayers of Ei (~10%  parasitemia) or E0 were prepared in 35- 
mm plastic petri dishes (No.  1008, 35 x  10 mm; Falcon Labware, Oxnard, CA) and were 
treated with  1 ml coating buffer followed by 1 ml of the  1% E suspensions. Nonadsorbed 
E were aspirated with a Pasteur pipette and the monolayers were washed once with  1 ml 
TBH. One confluent monolayer corresponded to ~22  x  106 E. The E monolayers were 
air-dried but not GA fixed. Lysates were prepared by sequential  incubation with 0.5 ml 
TBH for 30 rain at room temperature of three dishes containing either E~ or E0.  Under 
these conditions, most of the E membranes and parasites remained bound to the plastic. 
Before use the lysates were centrifuged at 1,000 g for 10 rain. A strongly positive Liberian 
serum, diluted  1:500, was then mixed with either TBH or lysate to a final serum dilution 
of 1:5,000 and used in the IF assay (IFA) as described. 
Culture supernatants.  Medium  (containing  10%  normal human serum)  in  which the 
parasites had been growing for ~24 h was collected from P.falciparum  cultures of 5-10% 
parasitemia.  The culture was centrifuged at 750 g for 10 min to sediment E~ and E0 and 
the supernatant was then centrifuged once more at 70,000 g for 30 min. 90 #l of different 
dilutions of the supernatant  were mixed with  10 #1 of a  hyperimmune  Liberian  serum 
and  were  used  in  the  IFA. The final  dilution  of the  immune  serum  in  these  tests  was 
1  : 1,000. In some experiments, the culture supernatants were processed further by passage 
over an immunoadsorbent prepared from another P. falciparum hyperimmune serum (see 
below). For inhibition of IF, both the passed and the eluted fractions of the supernatant 
were  used.  Elution  of the  material  adsorbed  to the  immunoadsorbent  was performed 
essentially as described by Jepsen and Andersen (21). From one liter culture supernatant 
applied to the column,  14 mg adsorbed protein were eluted with 3 M potassium thiocya- 
nate.  The material  was dialyzed against PBS and concentrated to 3  mg protein/ml.  For 
IF inhibition a series of four antigen dilutions was mixed with the hyperimmune serum. 
The final dilutions in the tests were  1:1,000 or  1:2,000 for the serum and 0.01-10 #g 
antigen  protein/m].  In  additional  experiments  the  eluates  were  similarly  tested  after 
incubation  in boiling water  for  5  min,  followed by centrifugation  to  remove  insoluble 
material. 
Parasite extracts.  The pelleted material obtained from the centrifuged culture super° 
natants (see above) was used. It was enriched in free merozoites but also contained pigment 
and some cell debris from both parasites and E. The pellet was washed twice in PBS and 
then sonicated on ice for two 30-s periods at 50 W (Bronson sonifier B-12; Bronson Sonic 
Power Co., Danbury, CT). The sonicate was freed from insoluble material by centrifuga- 
tion at  100,000 g  for 30 min. Sonicates of ghosts made from normal blood group O ÷ E 
as described (24) were prepared in the same way. Stock solutions of the sonicates containing 
6  rag  protein/mi  were  kept  frozen  until  use.  For  the  inhibition  assay,  90  ~1  of four 
different dilutions of the sonicates were diluted to 100 #1 with a hyperimmune Liberian 
serum, giving final serum dilutions of 1  : 1,000 and 0.06-60 #g/ml of the sonicates. 
Elution of Antibody from E Monolayers 
E monolayers were prepared  in plastic petri dishes (No.  1008; Falcon Labware), GA 
fixed, and air-dried.  Dishes containing either E~ (22 x  106 E/dish; parasitemia, 5-10%) or PERLMANN  ET  AL.  1689 
Eo were incubated with  1 ml/dish of a hyperimmune Liberian serum diluted  1:100 with 
TBH. After incubation for 30 min at 37°C and in the refrigerator overnight, the serum 
was aspirated and each dish was washed three times with  1-2 ml TBH containing 0.4% 
bovine serum albumin (BSA).  Four dishes with either Ei or Eo were then treated sequen- 
tially with  1 mi 0.2 M glycine buffer, pH 2.8, 2 min/dish. After the last dish, the buffer 
was neutralized by transfer to a tube containing 0.1  ml 2 M Tris-base. 0.1  ml of the eluate 
was used for IF and the rest for antigen analysis. 
Enzyme Treatment of E Monolayers 
Monolayers of either  El or  Eo on  multitest slides were  treated  with  enzymes either 
before or after GA fixation and drying. The enzymes used were trypsin (bovine pancreas, 
type  III, twice  crystallized,  9,440  U/mg;  Sigma  Chemical  Co.),  pronase  (nonspecific 
protease, Streptomyces  griseus, type XIV, 5.8 U/mg; Sigma Chemical Co.), or neuraminidase 
(Clostridium perfringens; Sigma Chemical Co.). One drop of enzyme solution at the concen- 
tration indicated below was added to each well for 30 min at 37°C.  Enzyme treatment 
was interrupted by washing with TBH containing 15% fetal calf serum. The slides treated 
with enzyme before fixation were then fixed with 1% GA and air-dried. 
Immunoadsorbent 
IgG from a  P. falciparum  hyperimmune  Liberian  serum  (Kinon)  was  prepared  by 
ammonium sulfate precipitation and DEAE Sephadex ion exchange chromatography as 
described (25).  The  IgG was coupled to cyanogen bromide-activated Sepharose (Phar- 
macia Fine Chemicals, Uppsala, Sweden) at a concentration of 5 mg per ml of gel (65 ml 
gel total) and the coupled gel was packed in a column (K26140; Pharmacia Fine Chemicals). 
Immunoblotting 
Immunoblotting was performed essentially as described previously (26).  One ml IgG of 
immune serum (1  mg IgG/ml) or of the antibody preparation eluted from E monolayers 
(El or E0) was diluted with 2 ml incubation buffer (PBS,  1% BSA, 0.1%  Triton X-100, 
0.02% sodium dodecyl sulfate [SDS], and 0.02% NAN3) and incubated with nitrocellulose 
strips containing electrophoretically transferred polypeptides from SDS-polyacrylamide 
gel electrophoresis (PAGE) separations of either merozoite-enriched parasite preparations 
or soluble culture  supernatant antigens eluted  from an immunoadsorbent (see above). 
Antibodies  bound  to  the  blotted  polypeptides  were  detected  by staining  for alkaline 
phosphatase (ALP) after reaction of the strips with rabbit anti-human  IgG (polyvalent) 
conjugated with ALP. 
In some experiments, metabolically radiolabeled parasite material was used. P. falcipa- 
rum cultures (5%  haematocrit, 5-10% parasitemia) were labeled for  15 h  with L-(75Se)- 
selenomethionine (25 #Ci/ml  medium,  20-50  Ci/mmol; Radiochemical Centre,  Amer- 
sham, United  Kingdom) in methionine-free medium (Parker  199;  State Bacteriological 
Laboratories, Stockholm). A merozoite-enriched fraction was prepared as described above 
and was used as antigen in immunoblotting experiments (~5 ×  10 ~ cpm per nitrocellulose 
strip). After development of the immunoblottings, the nitrocellulose strips were subjected 
to autoradiography for 3-5 d, using Kodak X-Omat RP film and an intensifying screen. 
ELISA 
The content of antibodies to P. falciparum  or E in different sera was determined as 
described elsewhere. The parasite antigen was a sonicate of trophozoite/schizont-enriched 
fractions obtained by Percoll gradient centrifugation (Pharmacia Fine Chemicals) of the 
laboratory cultures (23). 
Cell ELISA.  To determine the antibodies binding to the surface of GA-fixed El, a cell 
ELISA was developed. The wells of micro-ELISA plates were treated with bicarbonate 
coating buffer, pH 9.6.  Fifty ~l/well of a  1% suspension of E~ (~10% parasitemia) or E0 
were added  and  incubated  for 30  min  at room temperature.  Nonattached  cells were 
removed by gentle flooding of the plates with TBH and aspiration. Washing was repeated 
three times, leaving the bottom layer wet every time.  100 ~1 of 1% GA was then added 1690  ANTIGENS  ON P.  FALCIPARUM-INFECTED ERYTHROCYTES 
to each well and removed immediately by shaking of the plates upside down. Fixation was 
repeated once. The plates were then washed with distilled water, air dried, and stored at 
-20°C  until  use. In both  ELISA  systems the antibody content of different sera  was 
determined with an ALP-conjugated  rabbit  anti-human  immunoglobulin  serum as de- 
scribed (23). 
Results 
When monolayers of GA-fixed and air-dried E were incubated with P. falci- 
parum-immune  serum  and  then  tested in  the  indirect  IFA, a  distinct surface 
staining of Ei was observed.  No staining was obtained with sera from controls 
never exposed  to  malaria.  Fresh  E  or  E  which  had not  been  air  dried after 
fixation were not stained. Immunofluorescence was restricted to the surface of 
parasitized E,  as seen by counterstaining of the parasite nuclei with ethidium 
bromide (Fig.  1 a-c).  By using this double staining procedure, positive 1F could 
easily be related to the maturity of the parasite. Whereas E containing rings and 
trophozoites displayed strong IF (Fig. 2 a), it was usually absent or very weak on 
E containing schizonts. IF was an early event, already comprising large parts of 
the E surface when the merozoite penetrated the E (Fig. 2 b). Very rarely, staining 
of noninfected E  around  a  bursting  schizont  was  observed  (Fig.  2c).  IF  of 
intracellular parasites was not seen. 
The IF shown above was obtained by exposing E infected by in vitro culture 
with our laboratory strain (Tanzania) to sera of acutely infected patients from 
Colombia or Sweden. Exactly the same results were obtained when parasitized E 
from acutely infected patients were exposed to the patient's own serum (Fig. 
2 d). To check for possible strain specificity, P. falciparum-infected  E from four 
Colombian,  two  Tanzanian,  and  two  Kenyan  patients  were  tested  with  E 
surface-positive  sera  of either  Colombian  or  African  origin.  IF  was  similar 
throughout. Sera from five patients acutely infected with P. vivax, three infected 
with P. ovale, and one with P. malariae were also tested with P. falciparum-infected 
E. Two P. vivax, one P. ovale, and the P. malariae serum gave a positive E surface 
IF. The  rest were  negative. However, the  positive sera  were from Indian or 
African donors and had positive P. falciparum  titers in ELISA, suggesting that 
the donors had previously also been exposed to P. falciparum.  In contrast, the 
sera that were negative in this group were from Swedish patients with primary 
infections. P.  vivax-infected  E  from  seven  acutely infected patients were  not 
stained by either P. vivax sera or by some of the most reactive P, falciparum sera 
available on our panel. 
Sera from 60 P. falciparum patients or immune individuals were screened for 
reactivity in the E surface IFA and in ELISA with total P. falciparum antigen as 
described by Wahlgren et al. (23).  The serum dilutions used for screening were 
1:10  for IFA and  1:1,000  for ELISA. In general, Swedish or Colombian sera 
(acute infections) giving an OD405 of <0.8 in ELISA were also negative in the E 
surface IFA.  Sera giving ELISA values -~0.8  at the  1:1,000  dilution (39  sera) 
were then subjected to endpoint titration in IFA (Fig.  3),  While the sera from 
four ELISA-positive Colombians and three Swedes were negative, all others were 
positive in the E surface IFA. However, there was no correlation between IFA 
titers and the strength of ELISA against total P. falciparum antigen. To design 
an ELISA permitting a more restricted identification of antigens on the surface PERLMANN  ET  AL.  1691 
FIGURE  1.  Indirect IF of GA-fixed and air-dried monolayers of P. falciparum-infected  eryth- 
rocytes (laboratory strain) exposed to malarial sera from a  Colombian donor. The parasite 
nuclei were counterstained with ethidium bromide, parasitemia -10%. (a) IF (green) of surface 
of trophozoite containing E and intracellular fluorescence of parasite nuclei (orange); (b) the 
same field but only showing parasite nuclei, o4" (c) E surface IF. 1692  ANTIGENS  ON  P.  FALCIPARUM-INFECTED  ERYTHROCYTES 
FIGURE 2.  Indirect IF of GA-fixed and air-dried monolayers of P. falciparum-infected  eryth- 
rocytes (for further explanations see Fig. 1). (a, b) Double-stained E containing  young tropho- 
zoites or penetrating merozoites, respectively; (c) surface IF of noninfected E around bursting 
schizont;  merozoite  nuclei counterstained; (d)  IF  of parasitized  E  freshly  drawn  from  a 
Colombian patient and stained with the patient's own serum; parasite nuclei counterstained. 
of infected E, we developed a  cell ELISA in which monolayers of GA-fixed and 
dried  E  were  used  as  antigen.  Fig.  4  shows  the  results  of a  representative 
experiment with a P. falciparum-immune  Liberian serum and a  normal control 
serum tested with either Ei or E0. As seen, the immune serum gave a strong and 
dose-dependent reaction with Ei, significantly different from the three controls. 
In  Table  I,  three  sera  with  IFA  titers  ~1:625  were compared with  three  sera 
having IFA titers ~< I : 125. For the cell ELISA, the sera had to be used at relatively 
high  dilutions  to  eliminate  background  binding  to  E0.  This  was  probably  the 
main reason  for the absence of specific reactions with the low°titered sera.  On 
the  other  hand,  sera  with  elevated  IFA  titers  always  gave  strong  and  highly 
specific reactions in the cell ELISA. 
To elucidate the nature of the antigens responsible for the binding of antibod- PERLMANN  ET  AL.  1693 
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FIGURE 3.  Comparison of ELISA (total P. falciparum antigen) and E surface IFA. (Abscissa) 
Reciprocals of highest serum dilutions  giving positive surface IF of E infected with P. falciparum 
laboratory strain, ~10% parasitemia; (ordinate) ELISA values (OD405) at  serum dilution 
1:1,000 (O, O, F1) Swedish, Liberian, or Colombian sera, respectively. Sera giving ELISA 
values ~<0.8 not included. 
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FIGURE 4.  Cell  ELISA. (Abscissa) Serum dilutions; (ordinate) OD4o5; (0, O) P. falciparum- 
immune serum (Liberian); (I-I, II) normal human serum (Swedish); (O, II) P. falciparum-infected 
E,  10% parasitemia; (O, I-I) noninfected  E. 
ies  to  the  surface  of Ei,  the  cells  were  treated  with  proteolytic  enzymes  or 
neuraminidase. Some Ei monolayers in multitest slides were treated with enzyme 
before fixation with GA. They were then washed, fixed, air-dried, and stained 
as described. As seen from Table II, under these conditions neither trypsin nor 
neuraminidase abolished IF which was indistinguishable from that of untreated 
cells. Pronase was also without effect except when added at very high concentra- 
tions. However, when enzyme treatment was performed after GA fixation and 
air drying, pronase  completely abolished staining at both concentrations used. 
In contrast neither trypsin nor neuraminidase affected antibody binding. 
To establish the origin of the antigens reacting in the E surface IFA, inhibition 
experiments were performed. The representative results of three out of a  total 
of eight independent experiments are shown in Table III. The soluble fraction 
of Ei  lysates  (~10%  parasitemia)  completely abolished  surface  IF  given  by  a 
strongly positive immune serum (Exp. 1) whereas the soluble fraction of E0 lysates 
had no effect. Similarly, the soluble fractions of sonicated, merozoite-enriched 
parasite preparations were fully inhibitory at a  concentration of 6  #g protein/ 1694  ANTIGENS  ON  P.  FALCIPARUM-INFECTED ERYTHROCYTES 
TABLE  I 
Comparison of E Surface IFA and Cell ELISA 
Sera*  IFA titers* 
Cell ELISA (OD4o5)* 
Ei  Eo 
Immune, group 1 
Lib 11  12,500  1.27  0.09 
AC  3,125  1.26  0.31 
Lib 6  625  0.57  0.17 
Normal  I  0  0.06  0.05 
Immune, group 2 
HM  125  0.37  0.29 
JC  25  0.18  0.29 
X27  5  0.15  0.19 
Normal  a  0  0.20  0.12 
* P.falciparum-immune sera with IFA titers ~> 1:625, dilution in cell ELISA 
1:4,000 (group 1) or ~1:125 and 1:1,000  (group 2). 
* Antigen: E  infected with P. falciparum laboratory strain, parasitemia 
~10%.  IFA titers are reciprocals of highest serum  dilution showing 
positive immunofluorescence. 
Mean values obtained with five normal sera; these sera had no IFA titers 
at lowest dilution tested (1:5). 
TABLE  II 
Surface IF of Enzyme-treated E * 
Enzyme treatment* 
Enzymes  Before fixation  After fixation 
and drying  and drying 
Trypsin 
400 #g/ml  +  (+) 
100 ~g/ml  +  + 
Pronase 
400 #g/ml  (+)  - 
1 O0 #g/ml  +  - 
Neuraminidase 
0.02 U/ml  +  + 
* IFA of El (-10% parasitemia) was done with a hyperimmune Liberian 
serum (Kinon), diluted 1  : 1,000. 
* 30 min at 37°C of E monolayers on multitest slides either before or 
after GA fixation and drying. +, strong IF; (+), weak IF; -, no IF. 
ml, while no inhibition was seen at 0.6 #g/ml (Exp. 2). In contrast, similar extracts 
made  from  normal  E  ghosts  were  not  inhibitory at  concentrations  >25  times 
higher.  Centrifuged  supernatants  from  cultures of the  laboratory P. falciparum 
strain were  inhibitory at a  dilution of 1:8.  When  passaged over an  immunoad- 
sorbent made  from the IgG fraction of the serum of a  healthy but P. falciparum- 
hyperimmune  Liberian donor,  most of its inhibitory activity disappeared (Exp. 
2).  This activity was fully recovered  in the material eluted from the immunoad- PERLMANN ET  AL. 
TABLE III 
Inhibition  of E surface IF* 
Exp.  Inhibitor*  Lowest  concentration needed 
for total inhibition* 
1  E~ lysate  14 × 107 E/ml, 9% parasitemia 
E~ lysate  __l 
Merozoite extract  6.5 t~g protein/ml 
E ghost extract  __! 
1695 
Culture supernatant 
Before IS passage  1:8 dilution 
After IS passage  1:2 dilution 
IS eluate  1 ug protein/ml 
Culture supernatant 
IS eluate 
IS eluate (100°C, 
5 rain, centrifuged) 
1 ug protein/ml 
1 ug protein/ml 
* P. falciparura laboratory culture  tested  with hyperimmune Liberian 
serum Gbor, final dilution  1:5,000 (Exp. I) or Kinon, final dilution 
1:1,000 (Exps. 2, 3). 
* See Material and Methods; IS, immunoadsorbent prepared from Kinon 
IgG. 
|  No inhibition with highest concentrations tested (14 X 107 E/ml and 
160 #g ghost protein/ml, respectively). 
sorbent  (Exps.  2  and  3).  Incubation  in  boiling  water  for  5  min  (27)  did  not 
noticeably affect the inhibitory capacity of these eluates. 
For closer studies of the antigens exposed on the surface of Ei, the antibodies 
binding to GA-fixed and air-dried  E  were isolated by acid elution.  Antibodies 
eluted from Ei monolayers were fully active in the E surface IFA when added to 
fresh  Ei monolayers.  No  IF was seen with similarly prepared  eluates from E0 
monolayers. These antibody preparations were used for antigen analysis. Soluble 
antigens from culture supernatants were first adsorbed to a P. falciparum-reactive 
immunoadsorbent, eluted, and subjected to SDS-PAGE on 5-15% gradient slab 
gels (26).  The separated antigens were then electrophoretically transferred to 
strips  of nitrocellulose  and  probed  either  with  the  total  IgG  fraction  of a  P. 
falciparum-hyperimmune  serum or with antibody eluates prepared as described 
above. In these experiments, the same Liberian serum (Kinon) was used both for 
preparing the antibody eluates, the immunoadsorbent, and for developing the 
immunoblots. The results of a typical experiment are shown in Fig. 5. Upon the 
addition of the ALP anti-human Ig conjugate and zymogram staining, all strips 
displayed a  strong but diffuse staining in the molecular weight regions typical 
for human Ig chains (t*, Y, light). The stained zones appeared also on the control 
strips not treated with Kinon antibodies, indicating that the antigen preparation 
contained substantial amounts of human Ig. This was derived from the human 
serum present in the culture supernatant and was retained on the immunoadsor- 
bent,  which was rich in anti-Ig activity (Wahlgren, unpublished results).  When 
the antigen mixture was probed  with the total Kinon IgG, at least 25  distinct 1696  ANTIGENS  ON  P.  FALCIPARUM-INFECTED  ERYTHROCYTES 
FIGURE .5.  Reactivity of antibodies  to immunoadsorbent-purified P. falciparum cuhure super- 
natant antigens (A, B, and C) and antigens of a merozoite-enriched fraction of P. falciparum 
(D, E, and F) after electrophoretic transfer of polypeptides from SDS-PAGE to nitrocellulose 
membranes. (A, D) Polypeptides recognized by antibodies eluted from monolayers of normal 
human E; (B, E) polypeptides recognized by antibodies eluted from monolayers containing P. 
fatciparura-infected  E;  (C,  F)  polypeptides recognized  by  whole  IgG  from  P. fatciparum- 
hyperimmune serum  (Kinon);  (G, H) autoradiograms of nitrocellulose strips to which  the 
polypeptides of a 'SSe-methionine-labeled  merozoite-enriched fraction of P. falciparum  were 
transferred after SDS-PAGE.  In H,  the autoradiogram has been overexposed in order to 
visualize  the weakly labeled polypeptide at  155  K (arrow). Numbers indicate approximate 
molecular weights x  10  -s. 
bands  of widely differing molecular weights  were observed.  In  contrast,  the 
antibodies eluted from Ei monolayers reacted with only a few of the transferred 
polypeptides, primarily a doublet of  Mr 155,000 (155 K) and two faster migrating 
bands of Mr 135  K and  120 K, respectively. Some weakly stained bands in the 
70-80  K mol wt region were seen in some but not all experiments. The three 
slower migrating bands also appeared when the antigen mixtures were heated to 
100°C for 5 min before SDS-PAGE. However, none of these antigens was seen 
when the strips  were probed with eluates from E0  monolayers, indicating the 
absence of the corresponding antibodies in these preparations. 
To directly prove the origin of the antigens responsible for antibody binding 
to the surface of Ei, similar experiments were performed with extracts of  parasites 
metabolically  labeled  with  75Se-methionine.  The  antigen  source  was  soluble 
extracts of merozoite-enriched preparations,  prepared as described above and 
subjected to SDS-PAGE.  Probing of the nitrocellulose strips with Kinon serum 
showed  that  >20  antigenic  polypeptides  had  been  transferred,  including  a 
strongly stained  band  (doublet)  of Mr  155  K.  Autoradiograpby  of the  SDS- 
polyacrylamide gels indicated the presence of at least 20 radioactive bands and 
most  of  these  polypeptides  were  also  detected  on  the  nitrocellulose  strips, PERLMANN  ET  AL.  1697 
regardless of whether or not these were probed with antibodies. Comparison of 
the zymogram and the autoradiographs suggested that a majority but not all of 
the antigens made visible with the Kinon serum were of parasite origin.  These 
included a  155 K Mr polypeptide that was weakly but distinctly labeled (Fig. 5.) 
and was the predominating antigen when the strips were probed with antibodies 
eluted from E~ monolayers. In the zymograms, these strips also showed two weak 
bands of Mr 135 K and  120 K which were labeled in the autoradiographs.  These 
antibodies brought down three additional bands (110 K doublet, 90 K, and 52 
K) which had no counterparts in the autoradiographs and at least one of which 
(52  K) appeared  to be of erythrocyte origin.  There  were some fast-migrating 
components which, however, were also stained when the strips were probed with 
the  eluate  from  E0  monolayers.  The  nature  of these  components  is  under 
investigation. Parallel tests with E ghost polypeptides as antigen showed that the 
Kinon-IgG reacted with E polypeptides of Mr 220, 70, 65, 52, and 48 K but had 
no reactivity in the  155-120 K region (data not shown) (see 26). 
Discussion 
By means of an indirect  IFA, we have shown that sera from patients with P. 
falciparum  malaria  or from immune donors contain antibodies that bind to the 
surface of El.  With some very rare  exceptions (Fig.  2 c), antibody binding  was 
restricted to the surface of E~. It was most pronounced when the parasites were 
in early phases of their developmental cycle (ring stages, trophozoites) and was 
already seen when the merozoites penetrated uninfected host cells. In some sera 
the titers of the antibodies for this reaction were very high (>1:15,000). 
To demonstrate this antibody binding to Ei, we have developed a new indirect 
IFA in which E monolayers were very briefly fixed with dilute GA and air-dried 
before they were exposed to malarial  sera and anti-Ig  conjugate.  Under these 
conditions, the antibodies did not penetrate  the E membrane and intracellular 
parasites were not stained.  The presence of parasites in the antibody-binding E 
was demonstrated by counterstaining  with a  fluorescent nuclear dye similar to 
what has been described by others (28). 
As demonstrated  in  this  assay, antibody binding  was the  same regardless  of 
whether the Ei were obtained from cultures of a P. falciparum strain kept in the 
laboratory for many years or were freshly drawn from the blood of patients with 
acute infection. However, surface staining was never seen unless the E were air- 
dried. The reasons for this are not clear. Obviously, antibody staining reflects a 
change  in  the  surface  structure  of the  E  occurring  early  in  connection  with 
invasion,  but  the  corresponding  antigenic  structures  are  not  exposed before 
dehydration. This conclusion was also supported by experiments in which the E 
were treated  with pronase.  When  Ei were treated  before fixation  and  drying, 
subsequent  IF  staining  was  not affected.  In  contrast,  enzyme  treatment  after 
fixation and drying abolished antibody binding. 
The  E  surface  IF appeared  to be species specific since  strongly positive P. 
falciparum sera did not react with P. vivax-infected E. However, as we have not 
as yet seen any positive reactions when testing P. vivax-infected E with sera from 
patients with P. vivax malaria, we do not know whether the results reflect species 
specificity  of  the  antibodies  in  P. falciparum  sera  or  differences  in  antigen 1698  ANTIGENS  ON P.  FALCIPARUM-1NFECTED ERYTHROCYTES 
expression on E  infected with either one of these two plasmodial species.  In a 
rodent malaria system we have observed a similar antibody binding to the surface 
of P. chabaudi-infected mouse E exposed to sera from mice immunized with this 
parasite. These sera did not react with mouse E infected with P. yoelii. Moreover, 
there were no cross-reactions between P. chabaudi and P. falciparum when E and 
sera were tested in reciprocal combinations (unpublished results). 
Screening of many malarial  sera suggested that repeated or prolonged expo- 
sure to P. falciparum is a prerequisite for the appearance of antibodies giving the 
E surface IF described in this study. Thus, sera from residents of a holoendemic 
area  of Africa  (Liberia)  were all  positive.  In  contrast,  a  higher  frequency of 
negative reactions was found among Colombian and Swedish patients with acute 
malaria, particularly those suffering from their first infections. For the latter two 
groups, sera that displayed relatively low reactivity with total P. falciparum antigen 
in  ELISA  (23)  were  usually  also  negative  in  the  E  surface  IFA.  With  this 
exception,  there was no obvious correlation  between IF and  ELISA titers and 
some sera which gave strong ELISA reactions were negative in E surface IF. On 
the other hand, when GA-fixed and air-dried E were used in ELISA (cell ELISA) 
the correlation to the IFA was good, indicating that the two test systems detect 
the same antibodies. If confirmed by further experiments, the cell ELISA should 
be well-suited for screening of sera or B cell supernatants (29) for the occurrence 
of antibodies reacting with the surface of infected E. In particular,  it should be 
suitable for studies of the specificity of the antibodies in quantitative  inhibition 
experiments.  Its sensitivity can  probably be greatly  increased  by using  higher 
parasitemias and synchronized parasite cultures as antigen. 
The fact that certain sera were negative in the E surface IFA may mean that 
the relevant antibodies had  not been raised or were not available for reaction 
because of the formation of complexes with antigen present in the blood during 
the acute phase  of infection.  Alternatively,  antibodies  may recognize antigens 
that vary for different P. falciparum strains. The existence of inter- and intrastrain 
variability of plasmodial antigens on the E surface has been reported for both P. 
knowlesi (17, 30, 31) and P. falciparum  (16, 20, 32). Thus far, we have not seen 
this  variability,  since  the  sera  that  gave  positive  IF  with  our  laboratory  P. 
falciparum  culture  and  which  were from  different  parts  of the  world  reacted 
equally well with freshly isolated Ei from African or South American patients, 
including both heterologous and autologous serum/parasite combinations. How- 
ever, as our positive sera may have been polyspecific, the occurrence of a strain 
variation  in  the  E  surface IF is not excluded (20).  In an attempt  to study this 
problem we have recently also tested surface IF-positive antibodies from mono- 
clonal  B  cell  cultures,  obtained  by  Epstein-Barr  virus  transformation  of the 
lymphocytes of a  hyperimmune  Liberian  donor,  with  E  infected  either  with 
Tanzanian or Colombian parasites. In the experiments performed up to now, no 
differences  in  E  surface  IF  between  these  parasites  were  observed.  Further 
experiments,  using  both  human  monoclonal  antibodies  (29)  and  genetically 
defined parasite isolates, will be used to answer this important question. 
Treatment  of Ei after fixation and drying with neuraminidase  had no effect 
on  antibody  binding,  indicating  that  terminal  sialic  acid  residues  were  not 
involved in these reactions. Although treatment of the cells with trypsin was also PERLMANN  ET  AL.  1699 
without effect, treatment with pronase completely abrogated antibody binding, 
suggesting that the antigens were polypeptides. Treatment of the monolayers 
with  chloroform/methanol  (2:1)  did  not  change  antibody  binding,  arguing 
against the involvement of lipids (unpublished results). 
In accordance with the finding that Eo were not stained by immune sera was 
the fact that lysates of normal E  or extracts of normal E  membranes did not 
inhibit E surface IF even when added at very high concentrations. In contrast, 
antigens extracted from merozoite-enriched parasite preparations or present in 
centrifuged supernatants of P. falciparum  cultures gave an efficient and dose- 
dependent inhibition. The soluble supernatant antigens eluted from insolubilized 
antibodies of a hyperimmune Liberian serum were the most effective inhibitor 
of all those tested. Moreover, this inhibition was heat resistant, suggesting that 
the inhibitory antigens may be related to the S antigens, a serologically complex 
family of soluble, parasite-derived antigens of different molecular weights present 
both in patient sera and in supernatants of P. falciparum cultures (27, 33, 34). 
Plasmodial  infection  is  known  to  cause  substantial  changes  in  the  surface 
structure and composition of parasitized E (35).  Although our results strongly 
favored the conclusion that the antigens responsible for E surface IF were parasite 
derived,  they did  not  exclude  the  involvement of altered  host  components, 
recognized by antibodies present in malarial sera. Therefore, to further elucidate 
the nature and origin of these antigens, we analyzed them with antibodies eluted 
from the surface of Ei pretreated with a hyperimmune serum under conditions 
similar to those of the E surface IFA. Immunoblotting after SDS-PAGE of soluble 
and immunoadsorbent enriched antigens from P. falciparum cultures gave many 
bands when the blots were probed with the IgG fraction of the same hyperim- 
mune serum  as  was  used  to  prepare  the  immunoadsorbent.  However when 
probed with eluates made up of the E surface-binding antibodies from the same 
serum, a very restricted number of antigens was detected. The consistent finding 
was that of a distinct, strongly stained doublet of Mr 155,000 and of two faster- 
migrating bands  of lower  apparent  molecular weights  (135  K,  120  K).  The 
immunological relationship of these polypeptides to each other is not known. 
Similar results were obtained when the antigens were heat treated before SDS- 
PAGE, thus confirming the heat stability noted in the inhibition experiments. 
Further evidence for the origin of the antigens was sought by using extracts 
of metabolically labeled  parasites  (mainly merozoites)  as  the  antigen  source. 
Here, immunoblotting suggested that only one dominating antigen, also of Mr 
155  K, and some faster-migrating minor polypeptides were recognized by the 
antibodies  eluted  from  monolayers of Ei,  as  contrasted  to  >20  polypeptides 
recognized by immune serum. Three of these polypeptides, including the 155 K 
Mr band, were also among the ~20 bands which were radioactive according to 
the autoradiographs. Labeling with 75Se-methionine of the 155 K Mr polypeptide 
was weak but significant. The results further support the conclusion that the E 
surface IF seen by us was due to parasite-derived antigens recognized by anti- 
bodies from patients or individuals with acquired P. falciparum  immunity. 
The occurrence of parasite antigens on the surface of infected E in malaria is 
well established (16, 17, 30-32, 36-39). In most instances, these antigens appear 
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assumed  to  be  inserted  into  the  E  surface by  the  parasites  from within  the 
infected host cell (35). They have only been found on the surface of E containing 
mature trophozoites or schizonts. This is different from the findings reported 
here where the antigens were readily detected on Ei already at invasion and in 
the early phases of parasite development whereas they appeared to be absent 
from  schizont-containing  E.  Taken  together,  our  results  suggest  that  these 
antigens are released from bursting schizonts or merozoites and are deposited in 
the E membrane in connection with invasion. That antigens are released during 
schizont development and rupture or merozoite invasion has been reported (12, 
40,  41).  The antigens responsible for the E surface IF described by us may be 
part of the merozoite coat that is peeled off at invasion or may be released from 
the merozoite rhoptries (14, 42-44). Our findings further imply that they have 
affinity for receptor structures in the E membrane (45-47). It has recently been 
reported (48) that the major 195 K Mr glycoprotein found on the surface of P. 
falciparum schizonts is processed into fragments corresponding in size to those of 
the antigens described by us. Fragmentation appears to occur when the schizonts 
mature and merozoites are released. However, although the immune serum used 
in  our  antigen  analysis  contained  antibodies  that  recognized  the  195  K  Mr 
glycoprotein (Fig.  5  and  Berzins,  unpublished  results),  the antibody  fraction 
eluted from the surface of Ei did not.  Further investigations are required to 
establish the relationship of the antigens involved in the E surface interactions 
studied by us to that of other known parasite antigens described in the current 
literature. 
In recent experiments we have found that the antibodies eluted from fixed 
and  air-dried  monolayers  of  Ei  strongly  inhibit  parasite  reinvasion  in  vitro 
(W~hlin, manuscript in preparation). This suggests that the corresponding anti- 
gens may have an important role in the invasion process. Whether this involves 
the schizont burst,  a  recognition function necessary for merozoite attachment 
(45-47), or an alteration of the E membrane to facilitate merozoite penetration 
(49) is presently unknown. In any event, the experiments also suggest that the 
antibodies against these antigens may have a host protective function in malaria 
infection. If so, protection would probably not operate at the level of the Ei (e.g., 
by opsonization) since the antigens appear to be buried in the surface and are 
not readily accessible for antibody binding. For these reasons, the antibodies are 
probably also different from those believed to protect by blocking or reversal of 
sequestration of Ei (16).  Rather, a  possible protective action of the antibodies 
would be expected to  take place at  the level of the bursting schizont or free 
merozoites. Experiments intended to answer these questions are in progress. 
Summary 
Monotayers of human  erythrocytes (E) infected with PIasmodium falciparum 
were briefly fixed with 1% glutaraldehyde and air dried. They were then exposed 
to sera from patients with P. falciparum malaria or from donors immune to this 
parasite and tested in an indirect immunofluorescence assay (IFA). Parasites in 
infected E were made visible by counterstaining with ethidium bromide. Immu- 
nofluorescence (IF)  was  restricted to  the  surface of infected E.  No antibody 
binding  was  detected  unless  the  E  were dried,  suggesting  that  the  relevant PERLMANN ET  AL.  1701 
antigens  were not available on the outer layers of the E surface.  Staining  over 
large parts  of the  E  surface was seen already when  the  merozoite penetrated 
noninfected  cells and  was  strong  in  E  containing  early  stages  of the  parasite 
(rings,  trophozoites).  It was weak or absent from E containing  schizonts.  Anti- 
bodies  in  sera  from  different  parts  of Africa,  Colombia,  or Sweden  reacted 
similarly with  E  infected with a  Tanzanian  P. falciparum  strain  kept in  culture 
for many years and with parasitized E freshly drawn from African, Swedish, or 
Colombian patients. All sera from residents of a holoendemic area (Liberia) were 
IFA positive.  In contrast,  some sera from Colombian or Swedish patients  with 
primary infection gave negative results. The results of the IFA and of an enzyme- 
linked immunosorbent assay in which fixed and dried E were the targets were 
well-correlated, suggesting that the same antibodies were detected by these assays. 
The antigens involved in the IFA were susceptible to pronase but not to trypsin 
or neuraminidase.  E surface IF was inhibited by lysates of infected E, merozoite 
extracts,  or soluble antigens  present  in P. falciparum  culture supernatants  but 
not by lysates of normal E or ghost extracts.  The inhibitory antigens were heat 
stable (100 ° C, 5 min). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
followed by immunoblotting  of either antigen-enriched  preparations  from cul- 
ture  supernatants  or  merozoite  extracts  showed  that  antibodies  eluted  from 
monolayers of infected E  reacted consistently with a  predominant  polypeptide 
of Mr 155,000 and two to four minor polypeptides of lower molecular weights. 
Metabolic  labeling  of the  parasites  with  75Se-methionine  indicated  that  these 
antigens were parasite derived. We conclude that the antigens involved in these 
reactions are released from bursting schizonts or merozoites and are deposited 
in the E membrane in the course of invasion. A possible protective significance 
of the immune response to these antigens is suggested by preliminary experiments 
which showed that the antibodies eluted from infected E very efficiently inhibit 
E reinvasion by merozoites in vitro. 
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